Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2α and miR-494

Oncogenic Y‐box binding protein‐1 ( YBX 1) as an effective therapeutic target in drug‐resistant cancer

(2019) Michihiko Kuwano et al.   CANCER SCIENCE

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

(2019) Yingyao Zhou et al.   Nature Communications

Anticancer potential of rosmarinic acid and its improved production through biotechnological interventions and functional genomics

(2018) Mallappa Kumara Swamy et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Topoisomerases as anticancer targets

(2018) Justine L. Delgado et al.   BIOCHEMICAL JOURNAL

Schizandrin A enhances chemosensitivity of colon carcinoma cells to 5-fluorouracil through up-regulation of miR-195

(2018) Dongfang Kong et al.   BIOMEDICINE & PHARMACOTHERAPY

Chemotherapy and palliative care near end-of life: examining the appropriateness at a cancer institute for colorectal cancer patients

(2018) Ilaria Massa et al.   BMC Palliative Care

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Oral Administration of Prunella vulgaris L Improves the Effect of Taxane on Preventing the Progression of Breast Cancer and Reduces Its Side Effects

(2018) Jixue Zhao et al.   Frontiers in Pharmacology

Novel herbal medicine LA16001 ameliorates cisplatin-induced anorexia

(2017) Sang‑Mi Woo et al.   Molecular Medicine Reports

Spica Prunellae extract suppresses the growth of human colon carcinoma cells by targeting multiple oncogenes via activating miR-34a

(2017) Yi Fang et al.   ONCOLOGY REPORTS

Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway

(2017) Jiumao Lin et al.   ONCOLOGY REPORTS

Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells

(2017) Y Shen et al.   PHARMACOGENOMICS JOURNAL

Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy

(2015) Margarita González-Vallinas et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Hedyotis diffusa Willd overcomes 5-fluorouracil resistance in human colorectal cancer HCT-8/5-FU cells by downregulating the expression of P-glycoprotein and ATP-binding casette subfamily G member 2

(2015) QIONGYU LI et al.   Experimental and Therapeutic Medicine

Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-βPathway

(2014) Aling Shen et al.   Evidence-based Complementary and Alternative Medicine

Study on inhibitory effect of Spica Prunellae extract on T Lymphoma cell EL-4 tumor

(2013) X Mao et al.   African Journal of Traditional Complementary and Alternative Medicines

Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway

(2013) Wei Lin et al.   BMC Complementary and Alternative Medicine

Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells

(2013) WEI GU et al.   ONCOLOGY REPORTS

Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells

(2013) Margarita González-Vallinas et al.   PHARMACOLOGICAL RESEARCH

Anti-angiogenic effect of Spica prunellae extract in vivo and in vitro

(2012) Wei Lin   African Journal of Pharmacy and Pharmacology

Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma

(2012) Sumitaka Yamanaka et al.   CELL CYCLE

Prunella vulgaris Suppresses HG-Induced Vascular Inflammation via Nrf2/HO-1/eNOS Activation

(2012) Sun Mi Hwang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy

(2012) Shwu-Huey Liu et al.   JOURNAL OF ETHNOPHARMACOLOGY

Oroxylin a reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway

(2011) Hui-Ying Yang et al.   MOLECULAR CARCINOGENESIS

Reversal effect of 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU

(2011) Hai-ya Huang et al.   PHYTOMEDICINE

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy

(2009) Nicolas Tsavaris et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

(2009) Jolien Tol et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU

(2008) Lin-xi Shi et al.   CANCER LETTERS

Increased topoisomerase IIα expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis

(2008) Alan Coss et al.   CANCER LETTERS

Characterization of 5-Fluorouracil-Resistant Cholangiocarcinoma Cell Lines

(2008) Nisana Namwat et al.   CHEMOTHERAPY